Fundz

Synedgen Appoints Dr. Laura Saward, PhD, as Chief Scientific Officer

PRIVATEFeb 10, 2025

Position

Chief Executive Officer

Company

Synedgen

Laura Saward
lsaward@synedgen.com
ClaremontHealthcareHealth Care

Description

Synedgen, Inc announced the appointment of Dr Laura Saward, PhD, as the company’s Chief Scientific Officer. Dr Saward, an accomplished biotechnology executive with more than 25 years of experience in therapeutic drug development, will lead Synedgen’s scientific strategy to further the company’s development pipeline and government partnerships.

Quick answer

Synedgen Appoints Dr. Laura Saward, PhD, as Chief Scientific Officer (February 10, 2025). Synedgen is based in Claremont, California, United States.

Who is the new Chief Executive Officer at Synedgen?
Synedgen named Laura Saward Chief Executive Officer, announced February 10, 2025.
What did Synedgen announce on February 10, 2025?
Synedgen, Inc announced the appointment of Dr Laura Saward, PhD, as the company’s Chief Scientific Officer. Dr Saward, an accomplished biotechnology executive with more than 25 years of experience in therapeutic drug development, will lead Synedgen’s scientific strategy to further the company’s development pipeline and government partnerships.
What does Synedgen do?
Synedgen, Inc. is a biotechnology company developing Multivalent Innate Immune Signaling Target (MIIST) therapeutics that modulate and enhance the innate immune system.
Where is Synedgen based?
Synedgen is based in Claremont, California, United States.
Which similar companies made leadership changes around the same time?
Solera Health (February 14, 2025), TruLite Health (February 18, 2025), RefleXion Medical (February 19, 2025) and Climb Bio, Inc. (February 25, 2025) also announced leadership changes within 45 days of Synedgen.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Synedgen, and when

A new leader at Synedgen brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Synedgen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synedgen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synedgen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synedgen

Location

1420 N. CLAREMONT BOULEVARD

Claremont, California, United States

About

Synedgen, Inc. is a biotechnology company developing Multivalent Innate Immune Signaling Target (MIIST) therapeutics that modulate and enhance the innate immune system. The company’s lead development candidate is MIIST305, an oral, glycocalyx targeted induction and maintenance therapy for ulcerative colitis (UC). With US Government support, MIIST305 is also being developed in parallel as a medical countermeasure (MCM) for gastrointestinal acute radiation syndrome (GI-ARS). MIIST technology has been validated with clinical trials in partnered programs and extensively peer-reviewed through twenty-two (22) National Institutes of Health grants and Department of Defense contracts. Synedgen has an in-house GMP manufacturing facility.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synedgen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Laura
Likely contact at this company
••••••••@••••••••

See Laura's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Synedgen's next move

Learn about Strategic plan

Synedgen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.